These findings establish BACH1 as an essential downstream effector of BPC157, forming a functional BPC157-FBXO22-BACH1 signaling axis that governs HUVEC proliferation and angiogenic capacity
Unauthorized drug products are illegal in Canada and have not been assessed for safety, efficacy, and quality by Health Canada
Mechanisms of Action The precise receptor targets of BPC-157 have not been definitively mapped, and researchers note this remains an active area of investigation
Instead, research points to activity across multiple interconnected systems, including modulation of the nitric oxide (NO) system, upregulation of growth factor expression (notably VEGF, EGF, and FGF pathways), promotion of angiogenesis, and activation of the FAK-paxillin signalling pathway involved in cell migration and tissue organisation